We are live on ! Find out more
KYTH

KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH

Delisted

KYTH was delisted on the 30th of September, 2015.

Back to rankings

0 hedge funds and large institutions have $0 invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 142 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 143 → 0 (-143)

100% less funds holding in top 10

Funds holding in top 10: 12 → 0 (-12)

100% less capital invested

Capital invested by funds: $1.61B → $0 (-$1.61B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 142

Holders
–
Holders Change
-143
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
142
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$119M
2
PAI
Palo Alto Investors
California
-$84.4M
3
GF
Gabelli Funds
New York
-$80.2M
4
AA
AQR Arbitrage
Connecticut
-$74.8M
5
BFA
BlackRock Fund Advisors
California
-$72.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
51
TIAA CREF Investment Management
New York
– -$6.24M -83,230 Closed
Ameriprise
52
Ameriprise
Minnesota
– -$6.15M -82,038 Closed
Goldman Sachs
53
Goldman Sachs
New York
– -$6.1M -81,373 Closed
BCM
54
BlueCrest Capital Management
Jersey
– -$6.05M -80,681 Closed
EPM
55
Equitec Proprietary Markets
Illinois
– -$6.04M -80,600 Closed
LP
56
LMR Partners
United Kingdom
– -$6.03M -80,400 Closed
Charles Schwab
57
Charles Schwab
California
– -$5.85M -78,006 Closed
BNP Paribas Financial Markets
58
BNP Paribas Financial Markets
France
– -$5.15M -68,693 Closed
UOC
59
UBS O'Connor
Illinois
– -$4.91M -65,479 Closed
Adage Capital Partners
60
Adage Capital Partners
Massachusetts
– -$4.87M -65,000 Closed
KAM
61
Kassirer Asset Management
Ontario, Canada
– -$4.5M -60,000 Closed
JAM
62
JW Asset Management
Florida
– -$4.34M -57,925 Closed
Wells Fargo
63
Wells Fargo
California
– -$4.16M -55,538 Closed
WAM
64
Wolverine Asset Management
Illinois
– -$4.05M -53,983 Closed
SIM
65
Sonora Investment Management
Arizona
– -$3.63M -48,653 Closed
GC
66
Guggenheim Capital
Illinois
– -$3.59M -47,880 Closed
California State Teachers Retirement System (CalSTRS)
67
California State Teachers Retirement System (CalSTRS)
California
– -$3.53M -47,037 Closed
Citadel Advisors
68
Citadel Advisors
Florida
– -$3.42M -45,657 Closed
Bank of America
69
Bank of America
North Carolina
– -$3.38M -45,013 Closed
AllianceBernstein
70
AllianceBernstein
Tennessee
– -$3.29M -43,870 Closed
TI
71
Telemetry Investments
New York
– -$3.1M -41,400 Closed
RJA
72
Raymond James & Associates
Florida
– -$3.01M -40,178 Closed
SAM
73
Sandell Asset Management
New York
– -$3.01M -40,100 Closed
TA
74
Teachers Advisors
New York
– -$2.88M -38,351 Closed
Susquehanna International Group
75
Susquehanna International Group
Pennsylvania
– -$2.73M -36,461 Closed
1 2
3
4 5

KYTH Hedge Fund Activity: Q4 2015 in Review

0 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q4 2015, worth a combined $0 — down 100% from $1.61B a quarter earlier.

Sellers outnumbered buyers: 142 funds closed out of KYTH and 0 opened new positions — a net loss of 142 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Jennison Associates, exiting entirely with an estimated $119M sold.

  • 0 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q4 2015, down from 143 in Q3 2015.
  • Funds reported $0 of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q4 2015, down 100% quarter-over-quarter.
  • 0 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q4 2015 and 142 closed out, a net change of -142 holders.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q4 2015 was Jennison Associates, an estimated $119M sold.

Based on aggregated 13F filings for Q4 2015.